Dose escalation for localized prostate cancer: substantial benefit observed with 3D conformal therapy (Q73904611)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957249%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Dose escalation for localized prostate cancer: substantial benefit observed with 3D conformal therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957249%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Zvi Symon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957249%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Kent A Griffith

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957249%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P William McLaughlin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957249%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Molly Sullivan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957249%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Howard M Sandler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957249%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957249%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957249%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957249%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957249%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

384-390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957249%20AND%20SRC:MED&resulttype=core&format=json

External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

Full integration of the beam's eye view concept into computerized treatment planning

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

Potential improvement in the results of irradiation for prostate carcinoma using improved dose distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

Definitions of biochemical failure in prostate cancer following radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

The rush to judgment: Does the evidence support the enthusiasm over three-dimensional conformal radiation therapy and dose escalation in the treatment of prostate cancer?.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900569-8

7 January 2021

10.1016/S0360-3016(03)00569-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957249%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference